Li-Feng Chen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Ankylosing Spondylitis

Interstitial Lung Disease

Inflammatory Response

Signaling Pathway

Top Venues

Advances in rheumatology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Jing Zhang, Li-Feng Chen, Xu Li, Jian-Hua Chen, Zhang-Kui Tan
Tetramethylpyrazine alleviates hypoxia-induced proliferation, migration, and inflammatory response of fibroblast-like synoviocytes via inhibiting the HIF-1α- circCDC42BPB pathway. Advances in rheumatology (London, England) 64 (1) (2024)
Yu-Jing Zhang, Li-Feng Chen, Xu Li, Jian-Hua Chen, Zhang-Kui Tan
Tetramethylpyrazine alleviates hypoxia-induced proliferation, migration, and inflammatory response of fibroblast-like synoviocytes via inhibiting the HIF-1α- circCDC42BPB pathway. Advances in rheumatology (London, England) 64 (1) (2024)
Yu-Jing Zhang, Li-Feng Chen, Xu Li, Jian-Hua Chen, Zhang-Kui Tan
Tetramethylpyrazine alleviates hypoxia-induced proliferation, migration, and inflammatory response of fibroblast-like synoviocytes via inhibiting the HIF-1α- circCDC42BPB pathway. Advances in rheumatology (London, England) 64 (1) (2024)